Home
Carna Biosciences

Carna Biosciences Market Share Analysis for May 2026

Carna Biosciences is a clinical-stage biopharmaceutical company founded in April 2003 in Kobe, Japan to discover and develop innovative therapies to treat serious unmet medical needs, focusing on small molecule drugs, mainly targeting kinases. We also offer a broad range of high-quality products and innovative drug discovery services to scientists worldwide to help efficiently identify new kinase inhibitors.

Health > Biotechnology and Pharmaceuticals

Domaincarnabio.com

Year Founded2003

Employees51 - 200

Annual Revenue$500M - $1B

Carna Biosciences

Carna Biosciences (including company regionals)

carnabio.com

See more website traffic and engagement information

Carna Biosciences Revenue up to May 2026 is 500M - 1B

revenue generated by Carna Biosciences top domains

Carna Biosciences top domains revenue over 3 years

Revenue for Carna Biosciences top domains

carnabio.com500M - 1B

See more with Sales Intelligence

Total visits to Carna Biosciences's top domains

Understand Carna Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

carnabio.com14.8K

See more with Sales Intelligence

Avg. visit duration in Carna Biosciences's top domains

Analyze Carna Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

carnabio.com00:01:13

See more with Sales Intelligence

Avg. pageviews on Carna Biosciences's top domains

See how Carna Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

carnabio.com2.28

See more with Sales Intelligence

Carna Biosciences top competitors by domain

Top similar sites in May 2026, ranked by their affinity

cullinantherapeutics.comCompany NameCullinan TherapeuticsEmployees51 - 200HQUnited States, Massachusetts, CambridgeAnnual revenue$15M - $25MTotal visits4KN/A

Top technologies used by Carna Biosciences

These are the website technologies, by industry, used by Carna Biosciences top domains

Widget (2)

reCAPTCHA

Audio Video Media (1)

VideoJS

Conversion & Analytics (1)

Google Analytics

Email Services (1)

Will Cloud

More Technologies

4

See all

News & Signals from Carna Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCarnabio is developing AS-1763 in Greater China on Mar 7th '23.Carna Biosciences, a clinical-stage biopharmaceutical company focusing on the discovery and development of innovative therapies to treat serious unmet medical needs, today announced that it has regained the exclusive rights to develop and commercialize AS-1763 in Greater China from BioNova Pharmaceuticals Limited (BioNova).

NewsCarnabio is developing lipid kinase inhibitors.Carna has been engaged in a drug discovery program to develop lipid kinase inhibitors as next-generation immuno-oncology targets, and has chosen to license out to Gilead the exclusive rights to develop and commercialize this program worldwide.

NewsSeranovo partnered with Carnabio on Oct 30th '19.SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.